Articles Meeting the needs of cancer patients and healthcare provider... Complex and evolving cancer treatment pathways require comprehensive and tailored support programmes.
Views & Analysis Patient-led trials: a formula for success The benefits and pitfalls of patient-centric and patient-led trials.
Views & Analysis Health literacy: help pharma communicate with patients Health literacy study suggests more than 90% of adults need health information to be written for a reading age of 9-11 years.
Views & Analysis Dynamic consent models can benefit clinical trials Dynamic consent models for patients can develop ongoing partnership between participants and researchers.
Views & Analysis To PSP or not to PSP? That is NOT the question A practical guide to planning and running an effective patient support programme.
Views & Analysis Getting a rarer perspective Benefitting from insights from focus groups with rare disease patients.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
